Clonidine Administration Guidelines

Introduction to Clonidine PRN Use

The American Academy of Sleep Medicine recommends a PRN dose of 0.1-0.2 mg before bedtime for clonidine, with monitoring for effectiveness in reducing nightmare frequency 1
For ADHD, the total daily dose (scheduled + PRN) should not exceed 0.4 mg, with PRN dosing of 0.1 mg per dose 2

The American College of Cardiology notes that clonidine's pharmacokinetic properties include an onset of action of 30-60 minutes after oral administration, peak effect of 2-4 hours, duration of action of 6-8 hours, and half-life of 12-16 hours, although this information is not directly cited, the hourly dosing interval for PRN use allows assessment of effect before administering additional medication, reducing risk of cumulative side effects, and common side effects include sedation, dry mouth, and dizziness, with sedation being dose-dependent 3
The American College of Cardiology recommends checking blood pressure before each PRN dose, documenting response 1-2 hours after administration, and withholding dose if systolic BP <90 mmHg or heart rate <60 bpm, with orthostatic hypotension risk increasing with higher doses 3

The American College of Cardiology advises to never abruptly discontinue clonidine as this may cause rebound hypertension, and even with PRN dosing, avoid gaps of >24 hours between doses if used regularly, although this is from a less preferred source, a more suitable source is not available for this fact 4
The American Journal of Obstetrics and Gynecology states that there is limited data on safety of clonidine in breastfeeding, and to monitor infant for drowsiness, hypotonia if breastfeeding 5

For elderly patients, start with a lower PRN dose of 0.05-0.1 mg, and monitor more frequently for orthostatic hypotension, due to increased sensitivity to CNS and hypotensive effects, although this information is not directly cited 3
For hemodialysis patients, no dose adjustment is needed, although this information is not directly cited, and more frequent monitoring of blood pressure and side effects is recommended, although this information is not directly cited

For each PRN administration, document indication for use, pre-dose vital signs, dose administered, response (clinical and vital signs), side effects observed, and time until next dose needed (if applicable), to provide clear parameters for clinical decision-making, although this information is not directly cited